# LOTEMAX
> **NDA202872** · New Drug Application · Sponsor: BAUSCH AND LOMB INC · Approved 2012-09-28
## Drug
- **FDA Application Number:** NDA202872
- **Application type:** New Drug Application
- **Brand name:** LOTEMAX
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** GEL
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH AND LOMB INC
- **Manufacturer:** Bausch & Lomb Incorporated
- **First approval:** 2012-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202872)
---
*MORVS · CC0 1.0*